Answers are grounded in this paper and cite their sources.
This Medical News article discusses the US Food and Drug Administration’s new boxed warning requirement and investigation of secondary malignancies after CAR T-cell therapy.
No takes yet. Share an insight, caveat, or question.
Melissa Suran (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: